ESO ADVANCED COURSES, SEMINARS AND SYMPOSIA
ESO-ESMO-RCECLINICAL UPDATE ONRARE ADULT SOLID CANCERS25-27 November 2016Milan, Italy
Chairs: P.G. Casali, ITR.A. Stahel, CH
Held in collaboration with:
Flyer Rare Tumours (12 May)_screen 12.05.2016 15:52 Pagina 3
INTRODUCTION
Rare cancers make up as many as one fifth of all new cancer cases. Amongstthem, pediatric cancers and rare hematologic neoplasms are often covered bydedicated educational events, while adult solid rare cancers are hardlygrouped together and approached as a collective group of neoplasms.Indeed, they account for as many as 15% of all new cancer cases, thus beingthe main group within rare cancers. This Course is aimed at dealing with themon an annual basis, to provide the community of clinical oncologistsspecialising in these tumors with a regular update of recent advances in thisspecific area. The ultimate goal is to strengthen the educational coverage of agroup of cancers which may be neglected in spite of their collectiveincidence.
According to the RARECARE project, which provided a definition and a list ofrare cancers, rare adult solid cancers include the following big families oftumors, each of them being therefore covered by a correspondingeducational session within this Course:
• Rare skin cancers and non-cutaneous melanoma• Rare thoracic tumors • Rare female genital cancers• Neuroendocrine tumors • Endocrine gland tumors• Sarcomas• Digestive rare cancers • Rare urological and male genital tumors• Central nervous system neoplasms• Head and neck cancers
Any educational effort in the rare cancer area makes little sense ifdisconnected from a networking environment. Thus, this Course will be firstoffered to clinical oncologists involved into the existing networks coveringrare adult solid cancers, with a special attention to the new EuropeanReference Networks due to be created within the EU.
From the educational point of view, one cannot expect that even experiencedclinical oncologists are knowledgeable about all these tumors. For this reason,the European Faculty of this Masterclass is asked to focus on the most recentadvances, always trying to put them into the context of state-of-the-arttreatment of these tumors, with a special view to ESMO Clinical PracticeGuidelines.
Flyer Rare Tumours (12 May)_screen 12.05.2016 15:52 Pagina 4
FACULTY (as of May)
S. Bielack, Klinikum Stuttgart Olgahospital, Stuttgart, DE
J.Y. Blay, Centre Léon Bérard, Lyon, FR
P.G. Casali, Fondazione IRCCS Istituto Nazionale Tumori, Milan, IT
F. de Braud, Fondazione IRCCS Istituto Nazionale Tumori, Milan, IT
F. De Lorenzo, European Cancer Patient Coalition, Brussels, BE
A.P. Dei Tos, Azienda ULSS9, Treviso, IT
R. Elisei, Medicina Clinica e Sperimentale, Università di Pisa, IT
N. Fazio, European Institute of Oncology, Milan, IT
S. Ferrari, Istituti Ortopedici Rizzoli, Bologna, IT
M. Garassino, Fondazione IRCCS Istituto Nazionale Tumori, Milan, IT
R. Glynne-Jones, Mount Vernon Hospital, Northwood , Middlesex, UK
V. Gregoire, Universitè Catholique, Louvain, BE
S. Grisanti, A.O. Spedali Civili, Brescia IT
L. Licitra, Fondazione IRCCS Istituto Nazionale Tumori, Milan, IT
D. Lorusso, Fondazione IRCCS Istituto Nazionale Tumori, Milan, IT
N. Nicolai, Fondazione IRCCS Istituto Nazionale Tumori, Milan, IT
K. Õberg, University Hospital, Uppsala, SE
G. Pravettoni, European Institute of Oncology, Milan, IT
I. Ray-Coquard, Centre Léon Bérard, Lyon, FR
M. Seckl, Hammersmith Campus, London, UK
C. Simon, Université de Lausanne, CHUV Lausanne, CH
R. Soffietti, AOU San Giovanni Battista, Torino, IT
R.A. Stahel, Clinic for Oncology, Zurich, CH
A. Trama, Fondazione IRCCS Istituto Nazionale Tumori, Milan, IT
D.C. Weber, Proton Therapy Center, Villigen, CH
Flyer Rare Tumours (12 May)_screen 12.05.2016 15:52 Pagina 1
PROGRAMME
FRIDAY, 25 NOVEMBERINTRODUCTION
11:00 Welcome from ESO and ESMO A. Costa, IT R.A. Stahel, CH
11:15 Introduction P.G. Casali, IT11:30 The epidemiology of rare cancers A. Trama, IT11:45 The pathologic diagnosis in rare cancers A.P. Dei Tos, IT12:00 Patient empowerment in rare cancers G. Pravettoni12:15 The scenario of rare cancers in the EU F. De Lorenzo, BE12:30 Discussion
13:00 Lunch
SESSION 1 RARE THORACIC CANCERS
14:00 Mesothelioma R.A. Stahel, CH14:30 Thymic neoplasms M. Garassino, IT15:00 Discussion
15:30 Coffee break
SESSION 2 NEUROENDOCRINE TUMORS
16:00 Thoracic neuroendocrine tumors N. Fazio, IT16:30 Gastroenteropancreatic neuroendocrine tumors K. Oeberg, SE17:00 Discussion
SESSION 3 ENDOCRINE GLAND TUMORS
17:30 Thyroid cancer R. Elisei, IT18:00 Adrenal cancer S. Grisanti, IT18:30 Discussion
SATURDAY, 26 NOVEMBERSESSION 4 RARE FEMALE GENITAL TUMORS
8:00 Carcinoma of vagina and vulva D. Lorusso, IT8:30 Rare ovarian cancers I. Ray-Coquard, FR9:00 Trophoblastic tumors M. Seckl, UK9:30 Discussion
10:00 Coffee break
SESSION 5 SARCOMAS
10:30 Adult soft tissue sarcomas P.G. Casali, IT11:00 Gastrointestinal stromal tumors (GIST) J.Y. Blay, FR
Flyer Rare Tumours (12 May)_screen 12.05.2016 15:52 Pagina 5
11:30 Ewing sarcoma S. Ferrari, IT12:00 Osteosarcoma and other bone tumors S. Bielack, DE12:30 Discussion
13:00 Lunch
SESSION 6 RARE UROLOGICAL AND MALE GENITAL TUMORS
14:00 Testicular cancer N. Nicolai, IT14:30 Rare urinary cancers F. de Braud, IT15:00 Discussion
15:30 Coffee break
SESSION 7 RARE SKIN AND NON-CUTANEOUS MELANOMA
16:00 Skin adnexal tumors L. Licitra, IT16:30 Uveal and mucosal melanoma D.C. Weber, CH17:00 Discussion
SESSION 8 DIGESTIVE RARE CANCERS
17:30 Biliary tumors F. de Braud, IT18:00 Anal carcinoma R. Glynne-Jones, UK18:30 Discussion
SUNDAY, 27 NOVEMBERSESSION 9 HEAD AND NECK CANCERS
8:30 Laryngeal and hypopharyngeal cancer C. Simon, CH9:00 Oropharyngeal cancer V. Gregoire, BE9:30 Nasopharyngeal cancer L. Licitra, IT10:00 Oral cavity cancer C. Simon, CH10:30 Salivary glands cancers L. Licitra, IT11:00 Discussion
11:30 Coffee break
SESSION 10 CENTRAL NERVOUS SYSTEM TUMORS
12:00 Glioma R. Soffietti, IT12:30 cPNET Speaker to be announced13:00 Discussion
CLOSING REMARKS
13:30 Take home messages R.A. Stahel, CH
Flyer Rare Tumours (12 May)_screen 12.05.2016 15:52 Pagina 6
ORGANISING SECRETARIATEuropean School of OncologyRare Tumours Programmec/o Fondazione IRCCS Istituto Nazionale dei TumoriVia G. Venezian, 120133 Milano - ItalyFax +39 0223902531 - www.eso.netEmail: [email protected]
VENUESwiss Chamber - Sala MeiliVia Palestro, 220121 Milano - ItalyTel. +39 027632031www.swisschamber.it
REGISTRATION
GENERAL INFORMATION
Early(by 30 September 2016)
Late(from 1 October 2016)
Registration fee EUR 200
EUR 250Club ESO Members EUR 150
ESMO Members EUR 150
Rates are quoted in Euro and include VAT.Registration grants participation in all sessions, coffee breaks and lunches asindicated in the programme.
TRAVEL GRANTSTravel grants (registration, 2-night accommodation and travel expensescontribution, up to the total amount of the grant) are made available on acompetitive basis thanks to the support of Rare Cancers Europe. Priority will be given to younger candidates and low/middle income Countries.
Participants coming from:
• Italy EUR 650• Southern and Western Europe EUR 850• Northern, Central and Eastern Europe EUR 950• Other and overseas EUR 1150
Applications should be submitted by 30 September 2016 to: [email protected] include:
• Short curriculum vitae with full affiliation, contact details and date of birth;• Letter describing motivation for attending.
REGISTER ONLINE AT WWW.ESO.NET
Flyer Rare Tumours (12 May)_screen 12.05.2016 15:52 Pagina 7
ACCREDITATIONApplication for CME recognition will be submitted to Accreditation Council ofOncology in Europe (ACOE), to the European Accreditation Council forContinuing Medical Education (EACCME) and to the Italian CME accreditationsystem. EACCME credits are recognised by the American Medical Associationtowards the Physician’s Recognition Award (PRA).
Information on the status of the applications can be obtained from theorganising Secretariat.
CANCELLATION OF REGISTRATION OR REPLACEMENTCancellation should be notified to ESO in writing. In case of cancellation withoutreplacement, the fee, less handling charges of EUR 80, will be refunded after theevent, provided that the cancellation is received by ESO before 25 October.Replacements will be possible till 25 October.
BADGEThe badge is the only official evidence of registration and should be worn at alltimes during the event.
INSURANCEThe organisers bear no responsibility for untoward events in relation to theparticipation in the Course. Participants are advised to take out their ownpersonal and travel insurance.
OFFICIAL LANGUAGEThe official language will be English. No translation will be provided.
IMPORTANT DEADLINES Travel grants: 30 September 2016
Early registration: 30 September 2016
Late registration: from 1 October 2016
Flyer Rare Tumours (12 May)_screen 12.05.2016 15:52 Pagina 8
REGISTRATION FORM
CLINICAL UPDATE ON RARE ADULT SOLID CANCERS, 25-27 November 2016, Milan, ItalyPlease fill in this form in BLOCK CAPITALS and send by the deadline to:European School of Oncology - Via Turati 29 - 20121 Milan - Italy
Fax: +39 02 85464545 - E mail: [email protected]
ONLINE REGISTRATION AT WWW.ESO.NETPARTICIPANT'S DETAILS
Dr. Prof. Mrs. Mr.Surname NameInstituteDepartmentStreet Zip Code Town CountryPhone Fax MobileEmailProfession Specialisation Main fieldVAT number (compulsory for self-employed persons)
Fiscal code (Italian residents only)
If your invoice details are different to those above, please complete the following section:
Invoice contact personAddressPhone emailVAT number (compulsory for self-employed persons)
Fiscal Code (Italian residents only)
REGISTRATION FEES:Rates are quoted in Euro and include VAT.
Early Late(by 30 September 2016) (from 1 October 2016)
Registration fee EUR 200 EUR 250Club ESO Members EUR 150 EUR 250ESMO Members EUR 150 EUR 250
PAYMENT DETAILS:The registration is processed when payment accompanies the form (credit card details or copy of bank transfer)
Visa/Mastercard Card Number / / / Expire date / CV2 codeHolder’s name: and signature
BANK TRANSFER with no cost to the beneficiary (please provide a copy of the bank transfer): Bank: Banca Popolare di Milano, Agenzia 24 - Milan, ItalyAccount holder: European School of OncologyNumber: No. 16333 IBAN: IT96G0558401624 0000000 16333 - BIC: BPMIITMMXXXReference: "Rare Tumours" + participant’s name
I authorize the European School of Oncology to use my personal data according to what is specified in Article 13DLGS 196, available at www.eso.net or on request at fax number +39 02 8546 4545.
Signature Date
Flyer Rare Tumours (12 May)_screen 12.05.2016 15:52 Pagina 2
